Amy Peterson
2018 - BeiGene, Ltd.
In 2018, Amy Peterson earned a total compensation of $3.4M as Former Chief Medical Officer, Immuno, oncology at BeiGene, Ltd., a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Option Awards | $2,199,983 |
| Salary | $425,000 |
| Stock Awards | $549,851 |
| Other | $8,250 |
| Total | $3,395,584 |
Peterson received $2.2M in option awards, accounting for 65% of the total pay in 2018.
Peterson also received $212.5K in non-equity incentive plan, $425K in salary, $549.9K in stock awards and $8.3K in other compensation.
Rankings
In 2018, Amy Peterson's compensation ranked 3,358th out of 14,244 executives tracked by ExecPay. In other words, Peterson earned more than 76.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,358 out of 14,244 | 76th |
Division Manufacturing | 1,242 out of 5,765 | 79th |
Major group Chemicals And Allied Products | 433 out of 2,128 | 80th |
Industry group Drugs | 356 out of 1,817 | 80th |
Industry Pharmaceutical Preparations | 273 out of 1,391 | 80th |
Source: SEC filing on April 28, 2020.
Peterson's colleagues
We found five more compensation records of executives who worked with Amy Peterson at BeiGene, Ltd. in 2018.
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019